Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tubulin Modulators | 11 | 2019 | 106 | 1.660 |
Why?
|
| Tubulin | 15 | 2019 | 694 | 1.510 |
Why?
|
| Drug Design | 11 | 2019 | 1043 | 1.230 |
Why?
|
| Fluorescent Dyes | 10 | 2024 | 1927 | 0.780 |
Why?
|
| Structure-Activity Relationship | 19 | 2019 | 3053 | 0.640 |
Why?
|
| Spectroscopy, Near-Infrared | 5 | 2024 | 749 | 0.630 |
Why?
|
| Molecular Structure | 17 | 2019 | 1882 | 0.620 |
Why?
|
| Erythromycin | 4 | 2016 | 114 | 0.570 |
Why?
|
| Contrast Media | 3 | 2023 | 5329 | 0.570 |
Why?
|
| Antineoplastic Agents | 17 | 2023 | 13644 | 0.560 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2017 | 90 | 0.530 |
Why?
|
| Bibenzyls | 4 | 2016 | 11 | 0.510 |
Why?
|
| Periodontal Pocket | 1 | 2015 | 174 | 0.490 |
Why?
|
| Microwaves | 3 | 2014 | 183 | 0.470 |
Why?
|
| Bioreactors | 2 | 2015 | 244 | 0.470 |
Why?
|
| Triazoles | 1 | 2019 | 902 | 0.450 |
Why?
|
| Drug Screening Assays, Antitumor | 12 | 2019 | 718 | 0.450 |
Why?
|
| Xanthine Oxidase | 3 | 2019 | 69 | 0.420 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1617 | 0.400 |
Why?
|
| Waste Disposal, Fluid | 1 | 2012 | 34 | 0.390 |
Why?
|
| Enzyme Inhibitors | 4 | 2019 | 3723 | 0.370 |
Why?
|
| Phosphorus | 1 | 2012 | 336 | 0.350 |
Why?
|
| Monophenol Monooxygenase | 1 | 2010 | 72 | 0.350 |
Why?
|
| Agaricales | 1 | 2010 | 30 | 0.350 |
Why?
|
| Nitrogen | 1 | 2012 | 344 | 0.350 |
Why?
|
| Polymerization | 6 | 2019 | 154 | 0.350 |
Why?
|
| Magnesium Compounds | 1 | 2009 | 6 | 0.340 |
Why?
|
| Salicylates | 1 | 2010 | 127 | 0.340 |
Why?
|
| Iodides | 1 | 2009 | 39 | 0.340 |
Why?
|
| Stilbenes | 3 | 2015 | 155 | 0.340 |
Why?
|
| Ethers | 1 | 2009 | 72 | 0.330 |
Why?
|
| Cell Proliferation | 20 | 2019 | 10451 | 0.320 |
Why?
|
| Sodium Cyanide | 1 | 2008 | 9 | 0.320 |
Why?
|
| Formamides | 1 | 2008 | 22 | 0.320 |
Why?
|
| Potassium Cyanide | 1 | 2008 | 17 | 0.320 |
Why?
|
| Water Pollutants, Chemical | 1 | 2012 | 356 | 0.290 |
Why?
|
| Esters | 1 | 2008 | 212 | 0.290 |
Why?
|
| Bone and Bones | 2 | 2015 | 2559 | 0.290 |
Why?
|
| Amines | 1 | 2008 | 280 | 0.270 |
Why?
|
| Proteome | 1 | 2015 | 1894 | 0.250 |
Why?
|
| Biphenyl Compounds | 1 | 2010 | 1026 | 0.240 |
Why?
|
| Pyrazoles | 3 | 2019 | 2030 | 0.220 |
Why?
|
| Indocyanine Green | 1 | 2024 | 237 | 0.210 |
Why?
|
| Models, Molecular | 8 | 2019 | 5388 | 0.200 |
Why?
|
| Cyclobutanes | 1 | 2022 | 57 | 0.190 |
Why?
|
| Proteomics | 1 | 2015 | 3915 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2019 | 10745 | 0.190 |
Why?
|
| Cell Line, Tumor | 17 | 2024 | 17089 | 0.190 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2014 | 617 | 0.180 |
Why?
|
| Biological Products | 1 | 2009 | 948 | 0.170 |
Why?
|
| Benzyl Compounds | 1 | 2019 | 19 | 0.170 |
Why?
|
| Colchicine | 2 | 2018 | 257 | 0.160 |
Why?
|
| Models, Biological | 1 | 2015 | 9464 | 0.160 |
Why?
|
| Oxadiazoles | 1 | 2019 | 94 | 0.160 |
Why?
|
| Tissue Distribution | 3 | 2023 | 2275 | 0.160 |
Why?
|
| Ionophores | 3 | 2023 | 108 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13489 | 0.150 |
Why?
|
| Thiadiazines | 1 | 2017 | 9 | 0.150 |
Why?
|
| Quinoxalines | 1 | 2019 | 297 | 0.140 |
Why?
|
| Oxides | 1 | 2019 | 402 | 0.140 |
Why?
|
| Hydrazines | 1 | 2019 | 223 | 0.140 |
Why?
|
| Indoles | 2 | 2016 | 1834 | 0.140 |
Why?
|
| Binding Sites | 4 | 2019 | 6013 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 6105 | 0.140 |
Why?
|
| Sulfhydryl Compounds | 1 | 2018 | 296 | 0.140 |
Why?
|
| Thiones | 1 | 2016 | 50 | 0.130 |
Why?
|
| Campylobacter rectus | 1 | 2015 | 5 | 0.130 |
Why?
|
| Actinomyces | 1 | 2015 | 41 | 0.130 |
Why?
|
| Peritoneal Neoplasms | 1 | 2022 | 706 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 1189 | 0.120 |
Why?
|
| Maleic Anhydrides | 1 | 2014 | 8 | 0.120 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2016 | 273 | 0.120 |
Why?
|
| Ovarian Neoplasms | 2 | 2022 | 4903 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 1529 | 0.120 |
Why?
|
| Organoselenium Compounds | 1 | 2014 | 21 | 0.120 |
Why?
|
| Fasting | 1 | 2021 | 1609 | 0.120 |
Why?
|
| Maleimides | 1 | 2014 | 112 | 0.120 |
Why?
|
| Cytokinesis | 1 | 2015 | 170 | 0.120 |
Why?
|
| Static Electricity | 1 | 2015 | 258 | 0.120 |
Why?
|
| Fusobacterium nucleatum | 1 | 2015 | 176 | 0.110 |
Why?
|
| Organic Chemicals | 1 | 2015 | 211 | 0.110 |
Why?
|
| Carboxylic Acids | 1 | 2014 | 91 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 11094 | 0.110 |
Why?
|
| Solvents | 1 | 2015 | 299 | 0.110 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2019 | 616 | 0.110 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2015 | 391 | 0.110 |
Why?
|
| Databases, Protein | 1 | 2015 | 390 | 0.110 |
Why?
|
| HeLa Cells | 1 | 2019 | 3073 | 0.110 |
Why?
|
| Stereoisomerism | 3 | 2008 | 612 | 0.110 |
Why?
|
| Animals | 15 | 2024 | 168939 | 0.110 |
Why?
|
| Carbamates | 1 | 2014 | 191 | 0.100 |
Why?
|
| Thiazoles | 3 | 2017 | 1529 | 0.100 |
Why?
|
| Propanols | 1 | 2012 | 9 | 0.100 |
Why?
|
| Cycloparaffins | 1 | 2012 | 12 | 0.100 |
Why?
|
| Biological Oxygen Demand Analysis | 1 | 2012 | 5 | 0.100 |
Why?
|
| Electrolysis | 1 | 2012 | 8 | 0.100 |
Why?
|
| Aerobiosis | 1 | 2012 | 100 | 0.100 |
Why?
|
| Anaerobiosis | 1 | 2012 | 140 | 0.100 |
Why?
|
| Thiophenes | 1 | 2016 | 570 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1337 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1228 | 0.090 |
Why?
|
| Selenium | 1 | 2014 | 418 | 0.090 |
Why?
|
| Aniline Compounds | 1 | 2017 | 1079 | 0.090 |
Why?
|
| Alkynes | 1 | 2012 | 326 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 800 | 0.090 |
Why?
|
| Biofilms | 1 | 2015 | 641 | 0.090 |
Why?
|
| Nanoparticles | 2 | 2019 | 1966 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2015 | 2931 | 0.090 |
Why?
|
| Pyrazines | 1 | 2016 | 1204 | 0.090 |
Why?
|
| Mice | 9 | 2024 | 81898 | 0.090 |
Why?
|
| Diphosphonates | 1 | 2015 | 625 | 0.090 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2009 | 23 | 0.080 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 741 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 938 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 1198 | 0.080 |
Why?
|
| Benzoxepins | 1 | 2008 | 1 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2014 | 862 | 0.080 |
Why?
|
| Benzene | 1 | 2009 | 106 | 0.080 |
Why?
|
| Neoplasms | 4 | 2023 | 22350 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2016 | 1065 | 0.080 |
Why?
|
| Kinetics | 2 | 2019 | 6288 | 0.070 |
Why?
|
| Esterification | 1 | 2007 | 39 | 0.070 |
Why?
|
| Flavones | 1 | 2007 | 66 | 0.070 |
Why?
|
| Isoflavones | 1 | 2008 | 139 | 0.070 |
Why?
|
| RANK Ligand | 1 | 2009 | 321 | 0.070 |
Why?
|
| Humans | 33 | 2024 | 766812 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 1466 | 0.070 |
Why?
|
| Pyridines | 1 | 2018 | 2888 | 0.070 |
Why?
|
| Methylation | 1 | 2009 | 1076 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2015 | 4143 | 0.070 |
Why?
|
| Calcinosis | 1 | 2015 | 1480 | 0.070 |
Why?
|
| KB Cells | 2 | 2016 | 13 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2018 | 3043 | 0.060 |
Why?
|
| Kidney | 2 | 2019 | 7073 | 0.060 |
Why?
|
| Drug Delivery Systems | 3 | 2023 | 2210 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2016 | 464 | 0.060 |
Why?
|
| Protein Structure, Quaternary | 2 | 2016 | 424 | 0.060 |
Why?
|
| Cell Cycle | 3 | 2019 | 2925 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2009 | 2493 | 0.050 |
Why?
|
| Biological Availability | 1 | 2023 | 387 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2016 | 5990 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 3833 | 0.050 |
Why?
|
| Platinum | 1 | 2023 | 219 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 8715 | 0.050 |
Why?
|
| Cattle | 2 | 2019 | 3815 | 0.050 |
Why?
|
| Cyclization | 2 | 2012 | 59 | 0.040 |
Why?
|
| Hypertension | 1 | 2021 | 8616 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 41706 | 0.040 |
Why?
|
| Carboplatin | 1 | 2023 | 790 | 0.040 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 10263 | 0.040 |
Why?
|
| Protein Multimerization | 2 | 2016 | 961 | 0.040 |
Why?
|
| Trifluoroacetic Acid | 1 | 2019 | 5 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 2221 | 0.040 |
Why?
|
| Sulfuric Acids | 1 | 2019 | 36 | 0.040 |
Why?
|
| Formates | 1 | 2019 | 37 | 0.040 |
Why?
|
| Oxygen | 1 | 2012 | 4252 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1805 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2018 | 3948 | 0.040 |
Why?
|
| Asia | 1 | 2020 | 629 | 0.040 |
Why?
|
| Skull | 1 | 2023 | 819 | 0.040 |
Why?
|
| Phenols | 1 | 2022 | 526 | 0.040 |
Why?
|
| Tetrazolium Salts | 2 | 2007 | 92 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2007 | 1594 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2022 | 2478 | 0.040 |
Why?
|
| Cisplatin | 1 | 2023 | 1656 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2019 | 699 | 0.030 |
Why?
|
| Jurkat Cells | 2 | 2009 | 740 | 0.030 |
Why?
|
| beta-Cyclodextrins | 1 | 2016 | 67 | 0.030 |
Why?
|
| Carbon | 1 | 2019 | 672 | 0.030 |
Why?
|
| DNA Fragmentation | 1 | 2016 | 238 | 0.030 |
Why?
|
| Click Chemistry | 1 | 2016 | 100 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2014 | 5890 | 0.030 |
Why?
|
| Ligation | 1 | 2016 | 446 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 426 | 0.030 |
Why?
|
| Models, Chemical | 1 | 2017 | 607 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 293 | 0.030 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2015 | 136 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 2014 | 245 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3430 | 0.030 |
Why?
|
| Triglycerides | 1 | 2021 | 2441 | 0.030 |
Why?
|
| Ruthenium | 1 | 2012 | 18 | 0.030 |
Why?
|
| tau Proteins | 1 | 2023 | 2106 | 0.020 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 996 | 0.020 |
Why?
|
| Drug Carriers | 1 | 2016 | 702 | 0.020 |
Why?
|
| Injections | 1 | 2014 | 839 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 1150 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4570 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 9546 | 0.020 |
Why?
|
| Catalysis | 1 | 2012 | 767 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2470 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3886 | 0.020 |
Why?
|
| Pyrroles | 1 | 2015 | 1121 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4340 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3942 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 7475 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3618 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 2198 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 3759 | 0.020 |
Why?
|
| Apoptosis | 2 | 2016 | 9514 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2007 | 305 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2021 | 6422 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2021 | 54872 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 610 | 0.020 |
Why?
|
| Male | 3 | 2021 | 364154 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 9326 | 0.020 |
Why?
|
| Swine | 1 | 2014 | 5985 | 0.010 |
Why?
|
| Female | 3 | 2022 | 396532 | 0.010 |
Why?
|
| Cell Separation | 1 | 2009 | 1718 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1751 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2629 | 0.010 |
Why?
|
| Software | 1 | 2015 | 4464 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2007 | 5022 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 5502 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4349 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 5749 | 0.010 |
Why?
|
| Risk Factors | 1 | 2021 | 74889 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 12795 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 18986 | 0.010 |
Why?
|
Concepts
(218)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_